Eva Leitner

2.8k total citations
81 papers, 1.9k citations indexed

About

Eva Leitner is a scholar working on Molecular Medicine, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Eva Leitner has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Medicine, 26 papers in Infectious Diseases and 22 papers in Clinical Biochemistry. Recurrent topics in Eva Leitner's work include Antibiotic Resistance in Bacteria (27 papers), Bacterial Identification and Susceptibility Testing (22 papers) and Antimicrobial Resistance in Staphylococcus (13 papers). Eva Leitner is often cited by papers focused on Antibiotic Resistance in Bacteria (27 papers), Bacterial Identification and Susceptibility Testing (22 papers) and Antimicrobial Resistance in Staphylococcus (13 papers). Eva Leitner collaborates with scholars based in Austria, Germany and Switzerland. Eva Leitner's co-authors include Andrea Grisold, Gebhard Feierl, Martin Hoenigl, Gernot Zarfel, Egon Marth, Ines Zollner‐Schwetz, Robert Krause, Harald H. Kessler, Rolf Schröder and Thomas Valentin and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eva Leitner

77 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eva Leitner 538 414 412 348 347 81 1.9k
François Guérin 709 1.3× 418 1.0× 769 1.9× 500 1.4× 327 0.9× 129 2.7k
Chyi‐Liang Chen 576 1.1× 476 1.1× 681 1.7× 132 0.4× 113 0.3× 150 2.5k
Denis Spelman 665 1.2× 793 1.9× 800 1.9× 101 0.3× 278 0.8× 63 2.3k
Isao Nishi 377 0.7× 185 0.4× 246 0.6× 680 2.0× 112 0.3× 98 1.6k
Murray A. Abramson 344 0.6× 459 1.1× 384 0.9× 184 0.5× 295 0.9× 27 1.9k
Fabio Tumietto 1.1k 2.0× 404 1.0× 859 2.1× 110 0.3× 299 0.9× 53 2.1k
Marı́a Pérez-Vázquez 1.8k 3.3× 414 1.0× 1.3k 3.2× 199 0.6× 384 1.1× 99 3.4k
Wen‐Liang Yu 1.2k 2.2× 780 1.9× 616 1.5× 56 0.2× 211 0.6× 91 2.2k
Han-Sung Kim 486 0.9× 354 0.9× 307 0.7× 76 0.2× 177 0.5× 103 1.4k
Vassiliki Pitiriga 498 0.9× 102 0.2× 295 0.7× 262 0.8× 145 0.4× 52 1.2k

Countries citing papers authored by Eva Leitner

Since Specialization
Citations

This map shows the geographic impact of Eva Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Leitner more than expected).

Fields of papers citing papers by Eva Leitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Leitner. The network helps show where Eva Leitner may publish in the future.

Co-authorship network of co-authors of Eva Leitner

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Leitner. A scholar is included among the top collaborators of Eva Leitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Leitner. Eva Leitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luxner, Josefa, Eva Leitner, Andrea Grisold, et al.. (2024). A comparison of two MALDI-TOF MS based assays for the detection of carbapenemases in Enterobacterales. Scientific Reports. 14(1). 27086–27086. 1 indexed citations
2.
Wagner, Gabriel E., Michaela Lipp, Adriana Cabal Rosel, et al.. (2023). Real-Time Nanopore Q20+ Sequencing Enables Extremely Fast and Accurate Core Genome MLST Typing and Democratizes Access to High-Resolution Bacterial Pathogen Surveillance. Journal of Clinical Microbiology. 61(4). e0163122–e0163122. 34 indexed citations
3.
Kienesberger, Sabine, Eva Leitner, Bettina Halwachs, et al.. (2022). Enterotoxin tilimycin from gut-resident Klebsiella promotes mutational evolution and antibiotic resistance in mice. Nature Microbiology. 7(11). 1834–1848. 18 indexed citations
4.
5.
6.
Monecke, Stefan, Megan R. Earls, Eva Leitner, et al.. (2020). An epidemic CC1-MRSA-IV clone yields false-negative test results in molecular MRSA identification assays: a note of caution, Austria, Germany, Ireland, 2020. Eurosurveillance. 25(25). 6 indexed citations
7.
Leitner, Eva, et al.. (2020). Lack of sensitivity of an IVD/CE-labelled kit targeting the S gene for detection of SARS-CoV-2. Clinical Microbiology and Infection. 26(10). 1417.e1–1417.e4. 7 indexed citations
8.
Leitner, Eva, Gernot Zarfel, Josefa Luxner, et al.. (2017). Low prevalence of colonization with multidrug-resistant gram-negative bacteria in long-term care facilities in Graz, Austria. American Journal of Infection Control. 46(1). 76–80. 6 indexed citations
9.
Grisold, Andrea, et al.. (2016). Severe forefoot infection complicated by Fusobacterium russii. Anaerobe. 42. 162–165. 2 indexed citations
10.
Zarfel, Gernot, Josefa Luxner, Eva Leitner, et al.. (2016). Increase of genetic diversity and clonal replacement of epidemic methicillin-resistantStaphylococcus aureusstrains in South-East Austria. FEMS Microbiology Letters. 363(14). fnw137–fnw137. 22 indexed citations
11.
Hoenigl, Martin, Jasmin Wagner, Reinhard B. Raggam, et al.. (2014). Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria. PLoS ONE. 9(8). e104702–e104702. 34 indexed citations
12.
Putz‐Bankuti, Csilla, Harald H. Kessler, Thomas Valentin, et al.. (2013). Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir. SHILAP Revista de lepidopterología. 2013. 1–4. 1 indexed citations
13.
14.
Zarfel, Gernot, Martin Hoenigl, Eva Leitner, et al.. (2011). Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001–2010. Clinical Microbiology and Infection. 17(11). E5–E8. 25 indexed citations
15.
Valentin, Thomas, Eva Leitner, Ines Zollner‐Schwetz, et al.. (2010). Rifaximin intake leads to emergence of rifampin-resistant staphylococci. Journal of Infection. 62(1). 34–38. 44 indexed citations
16.
Huhulescu, Steliana, Eva Leitner, Gebhard Feierl, & Franz Allerberger. (2009). Laboratory-acquired Vibrio cholerae O1 infection in Austria, 2008. Clinical Microbiology and Infection. 16(8). 1303–1304. 7 indexed citations
17.
Grisold, Andrea, Gernot Zarfel, Martin Hoenigl, et al.. (2009). Occurrence and genotyping using automated repetitive-sequence–based PCR of methicillin-resistant Staphylococcus aureus ST398 in Southeast Austria. Diagnostic Microbiology and Infectious Disease. 66(2). 217–221. 37 indexed citations
18.
Kresken, Michael, Eva Leitner, Harald Seifert, Georg Peters, & Christof von Eiff. (2009). Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007). European Journal of Clinical Microbiology & Infectious Diseases. 28(8). 1007–1011. 16 indexed citations
19.
Gorkiewicz, Gregor, Gebhard Feierl, Eva Leitner, et al.. (2005). Identification of Glycopeptide-resistant enterococci by VITEK 2 system and conventional and real-time polymerase chain reaction. Diagnostic Microbiology and Infectious Disease. 53(1). 17–21. 13 indexed citations
20.
Raggam, Reinhard B., Eva Leitner, Jörg Berg, et al.. (2002). Qualitative detection of Legionella species in bronchoalveolar lavages and induced sputa by automated DNA extraction and real-time polymerase chain reaction. Medical Microbiology and Immunology. 191(2). 119–125. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Guérin Breakdown of academic impact, for papers by Chyi‐Liang Chen Breakdown of academic impact, for papers by Denis Spelman Breakdown of academic impact, for papers by Isao Nishi Breakdown of academic impact, for papers by Murray A. Abramson Breakdown of academic impact, for papers by Fabio Tumietto Breakdown of academic impact, for papers by Marı́a Pérez-Vázquez Breakdown of academic impact, for papers by Wen‐Liang Yu Breakdown of academic impact, for papers by Han-Sung Kim Breakdown of academic impact, for papers by Vassiliki Pitiriga
Rankless by CCL
2026